Correction to: Adv Ther https://doi.org/10.1007/s12325-020-01540-6
Global, likely CIDP (n = 222) | Global, somewhat likely CIDP (n = 204) | Global, unlikely CIDP (n = 169) | |||
---|---|---|---|---|---|
Sex, male, % | 46 | 39 | 51 | ||
Age (at diagnosis), n (%) | |||||
≤ 29 | 15 (6.76) | 16 (7.84) | 9 (5.33) | ||
30–39 | 32 (14.41) | 35 (17.16) | 19 (11.24) | ||
40–49 | 46 (20.72) | 50 (24.51) | 30 (17.75) | ||
50–59 | 69 (31.01) | 63 (30.88) | 49 (28.99) | ||
60–69 | 47 (21.17) | 29 (14.22) | 41 (24.26) | ||
70–79 | 12 (5.41)* | 10 (4.9) | 20 (11.83)* | ||
≥ 80 | 1 (0.45) | 1 (0.49) | 1 (0.59) | ||
Employment status (at diagnosis), % | |||||
Employed | 71 | 68 | 59 | ||
Paid full-time | 61 | 63 | 51 | ||
Paid part-time | 10 | 5 | 8 | ||
Retired | 11 | 7 | 20 | ||
Student | 2 | 3 | 2 | ||
On disability | 6 | 10 | 8 | ||
Unemployed | 5 | 4 | 5 | ||
Other/unpaid work | 5 | 7 | 6 | ||
Current treatment at survey completion, % | |||||
IVIg | 61 | 61 | 59 | ||
SCIg | 2 | 3 | 2 | ||
Corticosteroids | 23 | 22 | 15 | ||
IVIg and steroids | 12 | 14 | 9 | ||
Other immunosuppressive drugs | 15 | 17 | 18 | ||
Plasma exchange | 3 | 2 | 2 |